HS OBTAIN

By: THREAD

App for assessing the efficacy and safety of SAR442970 in moderate to severe HS.

Features & Capabilities

Your app for the HS OBTAIN study with Sanofi assessing the efficacy and safety of an anti-TNF-OX40L NANOBODY molecule, SAR442970 in participants with moderate to severe hidradenitis suppurativa.

User Growth & Download Statistics

App

By:

Downloads:

Version:

1.0.70 Last updated: 2024-03-04

Version code:

70

Creation date:

2023-10-02

Publisher country:

US

Permissions:

android.permission.ACCESS_COARSE_LOCATION Very high risk
android.permission.ACCESS_FINE_LOCATION Very high risk
android.permission.CAMERA Very high risk
android.permission.READ_PHONE_STATE Very high risk
android.permission.RECORD_AUDIO Very high risk
android.permission.READ_EXTERNAL_STORAGE High risk
android.permission.WRITE_EXTERNAL_STORAGE High risk
android.permission.BLUETOOTH_CONNECT Moderate risk
android.permission.BLUETOOTH_SCAN Moderate risk
android.permission.ACCESS_WIFI_STATE Low risk

Size:

82.03MB

Email:

Pr*****@threadresearch.com

URLs:

Website ,Privacy policy

Full description:

Source:

Google Play Store

Data ingested on:

2026-06-22

Compare stats and ranking:

Ranking

# 1,984,033 ▼ 11,381

For Developers

Monetize with App Pass Boost with Extension Booster

Contact the developer

Chrome-Stats does not own this Android app. Please use these information below to contact the Android app developer.

Developed by:

THREAD

Google Play Store

https://play.google.com/store/apps/details?id=com.thread.t7c806f7

Email:

Pr*****@threadresearch.com

Website:

https://www.threadresearch.com

Best HS OBTAIN Alternatives

Here are some Android apps that are similar to HS OBTAIN:

HSR Patients App

everywhereIM BV

Sanofi VAS00006 HARMONIE

Hidradenitis Suppurativa App

everywhereIM BV

GSK 214760 Patient

SAAVY (270-701)

Sanofi ACT17241

Clario Clinical eCOA

Jenevive Health